Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6268190rdf:typepubmed:Citationlld:pubmed
pubmed-article:6268190lifeskim:mentionsumls-concept:C0431085lld:lifeskim
pubmed-article:6268190lifeskim:mentionsumls-concept:C1442792lld:lifeskim
pubmed-article:6268190lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:6268190pubmed:issue3-4lld:pubmed
pubmed-article:6268190pubmed:dateCreated1981-11-18lld:pubmed
pubmed-article:6268190pubmed:abstractTextA perifusion system has been used to study the in vitro desensitization of isolated Leydig tumor cells. It was observed that the cells become refractory, as measured by decreased rates of steroidogenesis, during continuous perifusions with saturating concentrations of either human choriogonadotropin (CG), cholera toxin, or 8-bromo-cyclic AMP. Furthermore, an initial perifusion of the cells with either human CG, cholera toxin, or 8-bromo-cyclic AMP causes subsequent desensitization towards all three stimuli. Thus, each of these stimuli is equally effective in inducing a state of desensitization in these cells that is manifested by a steroidogenic lesion(s) distal to cyclic AMP formation. It was found that the post-cyclic AMP lesion(s) in the desensitized state occurs prior to the formation of pregnenolone. However, the decreased rates of steroidogenesis do not seem to arise from a depletion of intracellular cholesterol.lld:pubmed
pubmed-article:6268190pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6268190pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6268190pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6268190pubmed:languageenglld:pubmed
pubmed-article:6268190pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6268190pubmed:citationSubsetIMlld:pubmed
pubmed-article:6268190pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6268190pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6268190pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6268190pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6268190pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6268190pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6268190pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6268190pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6268190pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6268190pubmed:statusMEDLINElld:pubmed
pubmed-article:6268190pubmed:monthJullld:pubmed
pubmed-article:6268190pubmed:issn0006-3002lld:pubmed
pubmed-article:6268190pubmed:authorpubmed-author:AscoliMMlld:pubmed
pubmed-article:6268190pubmed:authorpubmed-author:PuettDDlld:pubmed
pubmed-article:6268190pubmed:authorpubmed-author:SegaloffD LDLlld:pubmed
pubmed-article:6268190pubmed:issnTypePrintlld:pubmed
pubmed-article:6268190pubmed:day17lld:pubmed
pubmed-article:6268190pubmed:volume675lld:pubmed
pubmed-article:6268190pubmed:ownerNLMlld:pubmed
pubmed-article:6268190pubmed:authorsCompleteYlld:pubmed
pubmed-article:6268190pubmed:pagination351-8lld:pubmed
pubmed-article:6268190pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6268190pubmed:meshHeadingpubmed-meshheading:6268190-...lld:pubmed
pubmed-article:6268190pubmed:meshHeadingpubmed-meshheading:6268190-...lld:pubmed
pubmed-article:6268190pubmed:meshHeadingpubmed-meshheading:6268190-...lld:pubmed
pubmed-article:6268190pubmed:meshHeadingpubmed-meshheading:6268190-...lld:pubmed
pubmed-article:6268190pubmed:meshHeadingpubmed-meshheading:6268190-...lld:pubmed
pubmed-article:6268190pubmed:meshHeadingpubmed-meshheading:6268190-...lld:pubmed
pubmed-article:6268190pubmed:meshHeadingpubmed-meshheading:6268190-...lld:pubmed
pubmed-article:6268190pubmed:meshHeadingpubmed-meshheading:6268190-...lld:pubmed
pubmed-article:6268190pubmed:meshHeadingpubmed-meshheading:6268190-...lld:pubmed
pubmed-article:6268190pubmed:meshHeadingpubmed-meshheading:6268190-...lld:pubmed
pubmed-article:6268190pubmed:meshHeadingpubmed-meshheading:6268190-...lld:pubmed
pubmed-article:6268190pubmed:meshHeadingpubmed-meshheading:6268190-...lld:pubmed
pubmed-article:6268190pubmed:meshHeadingpubmed-meshheading:6268190-...lld:pubmed
pubmed-article:6268190pubmed:year1981lld:pubmed
pubmed-article:6268190pubmed:articleTitleCharacterization of the desensitized state of Leydig tumor cells.lld:pubmed
pubmed-article:6268190pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6268190pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6268190pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6268190lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6268190lld:pubmed